They will be ensuring that they have the numbers for a statistical significant sample size. From memory this was mentioned that it was discussed to ensure data would be valid enough to proceed with EU and phase 3 trials. Would be suicide to cut corners at this point knowing that it wouldn't get through to next phase.
Ann: Screening to close as clinical trial nears completion, page-9
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable